N-urea Amino Acid Amides as Selective FPRL-1 Modulators
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapeutic agents lack effective modulation of the N-formyl peptide receptor like-1 (FPRL-1) receptor, which is crucial for managing excessive inflammatory responses in various diseases, including ocular inflammatory disorders.
Innovation Solution
Development of novel amide derivatives of N-urea substituted amino acids that act as potent and selective FPRL-1 modulators, including receptor agonists, antagonists, and partial agonists/antagonists, to treat disorders associated with FPRL-1 receptor modulation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current therapeutic agents are used, then treatment of inflammatory disorders is attempted, but effective modulation of FPRL-1 receptor is lacking
Solution Approach 1:
The patent employs parameter changes by systematically modifying the chemical structure of amino acid derivatives, specifically varying substituents at different positions (R1-R6 groups) to optimize FPRL-1 receptor modulation. This includes changing molecular weight, lipophilicity, and steric properties to achieve potent and selective agonist/antagonist activity at the FPRL-1 receptor, thereby resolving the contradiction between effective modulation and broad applicability to various inflammatory disorders
2Reliability
If novel amide derivatives of N-urea substituted amino acids are developed, then potent and selective FPRL-1 modulation is achieved, but complexity of compound structure increases
Solution Approach 1:
The patent applies segmentation by dividing the complex molecule into distinct functional modules: a core amino acid framework, N-urea substitution at the nitrogen position, and amide derivatives at the carboxyl position. This modular approach allows systematic optimization of potency and selectivity while maintaining a manageable structural complexity through defined substitution patterns at specific positions (R1-R6 groups)
Solution Approach 2:
The patent systematically varies chemical parameters including the nature of substituent groups (alkyl, aryl, heterocyclic), their positions on the molecular scaffold, and their stereochemistry. This controlled parameter exploration enables achievement of potent and selective FPRL-1 modulation while organizing structural complexity through rational design rather than random complexity
Data Source
AI summary
The present invention relates to novel amide derivatives of N-urea substituted amino acids, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the N-formyl peptide receptor like-1 (FPRL-1) receptor.